Reported 4 months ago
Neuralink, Elon Musk's brain-chip company, is planning to enroll three patients in a study to assess its brain implant device, expected to last several years. The U.S. government's clinical trials database reveals that Neuralink aims to enable paralyzed individuals to operate digital devices through thoughts alone, potentially benefiting those with spinal cord injuries. Despite prior criticism for lack of transparency, the FDA approved the study, with completion estimated by 2031, targeting patients aged 22 to 75 with limited mobility due to conditions like quadriplegia or ALS. The early feasibility study has begun, involving robotic implant surgery in a brain region controlling movement intentions, already showing promising results with the first patient being able to play video games and browse the internet through the device.
Source: YAHOO